LeMaitre Vascular Inc

LeMaitre Vascular insiders buy DERs, signaling confidence in future vascular‑device releases and a bullish outlook for the company’s growth.

Insider buying shows confidence in LMI’s growth prospects—SHADAN MARTHA’s DER purchases hint at future price momentum for the vascular device leader.

LeMaitre Vascular CEO’s cost‑free derivative buys show confidence in growth, but investors must watch earnings and product launches to confirm the upside.

LeMaitre Vascular CFO’s recent 2,000‑share buy signals insider confidence amid strong 21% YTD gains and upcoming FDA‑approved device launches, hinting at upside potential.